This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Universität De Barcelona. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Victor Manuel Díaz Cortés: Innovator in B-Cell Acute Lymphoblastic Leukemia Treatment
Introduction
Victor Manuel Díaz Cortés is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical research, particularly in the treatment of B-cell acute lymphoblastic leukemia (B-ALL). His innovative approach has led to the development of a unique patent that addresses this critical health issue.
Latest Patents
Victor holds a patent titled "CD22 TARGETING-MOIETY FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)." This patent represents a significant advancement in targeted therapies for leukemia, showcasing his commitment to improving patient outcomes.
Career Highlights
Victor is affiliated with the University of Barcelona, where he conducts research and collaborates with other experts in the field. His work has been instrumental in advancing the understanding and treatment of B-ALL, making him a key figure in medical innovation.
Collaborations
He has worked alongside talented colleagues such as Pablo Menéndez Buján and Samanta Romina Zanetti. Their collaborative efforts have contributed to the success of his research and the development of effective treatment strategies.
Conclusion
Victor Manuel Díaz Cortés is a pioneering inventor whose work in leukemia treatment exemplifies the impact of innovation in medicine. His contributions continue to inspire advancements in healthcare and improve the lives of patients facing challenging diagnoses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile